Analyses of optimal body mass index for infertile patients with either polycystic or non-polycystic ovary syndrome during assisted reproductive treatment in China.
We observed the effect of body mass index (BMI) on pregnancy outcomes in Chinese patients undergoing assisted reproductive treatment (ART). All the patients were divided into polycystic ovary syndrome (PCOS) group and non-PCOS group, and then according to BMI, each group was subdivided into 6 subgroups: group 1 (BMI < 18 kg/m2), group 2 (18-20 kg/m2), group 3 (20-22 kg/m2), group 4 (22-24 kg/m2), group 5 (24-26 kg/m2) and group 6 (BMI > 26.0 kg/m2). We found that in 20 to 25-year-old patients, the pregnancy rate was not significantly correlated with BMI in PCOS patients; while in non-POCS patients, the pregnancy rate significantly decreased at the BMI cut-off point value of 24-26 kg/m2. The pregnancy rate significantly declined at the BMI cut-off point values of 22-24 kg/m2and 18-20 kg/m2, respectively in 25 to 35-year-old and in over 35-year-old PCOS patients; while in over 25-year-old non-PCOS patients, no significant correlation between pregnancy rate and BMI was observed. We conclude that for under 25-year-old non-PCOS patients, ART should be performed after BMI is controlled under 26 kg/m2. For PCOS patients, if age is 25 to 35 years or over 35 years, BMI should be controlled below 24 kg/m2or below 20 kg/m2, respectively.
Reproductive Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Fang
F
Wang
Reproductive Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Wei
W
Dai
Reproductive Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Xin-Hong
XH
Yang
Reproductive Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Yi-Hong
YH
Guo
Reproductive Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Ying-Pu
YP
Sun
Zhonghua Liu Xing Bing Xue Za Zhi. 2002 Feb;23(1):5-10
12015100
Clin Endocrinol (Oxf). 2007 Apr;66(4):513-7
17371468
J Assist Reprod Genet. 2001 Jul;18(7):382-6
11499322
Arch Gynecol Obstet. 2004 Dec;270(4):205-10
12955532
Reprod Biomed Online. 2012 Sep;25(3):227-41
22809865
Reprod Biomed Online. 2008 Jun;16(6):765-71
18549684
Pathophysiology. 2008 Aug;15(2):115-21
18599275
Hum Reprod Update. 2011 Jan-Feb;17(1):17-33
20639519
Fertil Steril. 2008 Dec;90(6):2304-9
18191852
Mol Cell Endocrinol. 2011 Mar 15;335(1):30-41
20708064
Reprod Biomed Online. 2011 Oct;23(4):421-39
21885344
Reprod Biomed Online. 2008 Jun;16(6):778-83
18549686
Fertil Steril. 2010 Feb;93(2):447-54
19171335
Fertil Steril. 2009 Jul;92(1):256-61
18692801
Fertil Steril. 2004 Jan;81(1):19-25
14711538
Gynecol Endocrinol. 2010 May;26(5):325-32
20192898
N Engl J Med. 2004 Sep 2;351(10):987-97
15342807
Fertil Steril. 2009 Apr;91(4):1056-60
18325506
Aust N Z J Obstet Gynaecol. 2012 Jun;52(3):270-6
22694077
Fertil Steril. 2008 Sep;90(3):714-26
18068166